These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 26449721)
1. Amphetamine increases activity but not exploration in humans and mice. Minassian A; Young JW; Cope ZA; Henry BL; Geyer MA; Perry W Psychopharmacology (Berl); 2016 Jan; 233(2):225-33. PubMed ID: 26449721 [TBL] [Abstract][Full Text] [Related]
2. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA Psychopharmacology (Berl); 2010 Feb; 208(3):443-54. PubMed ID: 20020109 [TBL] [Abstract][Full Text] [Related]
3. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA Pharmacol Biochem Behav; 2010 Jul; 96(1):7-15. PubMed ID: 20363246 [TBL] [Abstract][Full Text] [Related]
4. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Perry W; Minassian A; Paulus MP; Young JW; Kincaid MJ; Ferguson EJ; Henry BL; Zhuang X; Masten VL; Sharp RF; Geyer MA Arch Gen Psychiatry; 2009 Oct; 66(10):1072-80. PubMed ID: 19805697 [TBL] [Abstract][Full Text] [Related]
5. Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania. Milienne-Petiot M; Geyer MA; Arnt J; Young JW Psychopharmacology (Berl); 2017 Mar; 234(6):1017-1028. PubMed ID: 28160035 [TBL] [Abstract][Full Text] [Related]
6. Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features. van Enkhuizen J; Milienne-Petiot M; Geyer MA; Young JW Psychopharmacology (Berl); 2015 Sep; 232(18):3455-67. PubMed ID: 26141192 [TBL] [Abstract][Full Text] [Related]
7. Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder. van Enkhuizen J; Geyer MA; Halberstadt AL; Zhuang X; Young JW J Affect Disord; 2014 Feb; 155():247-54. PubMed ID: 24287168 [TBL] [Abstract][Full Text] [Related]
8. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice. van Enkhuizen J; Geyer MA; Kooistra K; Young JW Int J Neuropsychopharmacol; 2013 Jun; 16(5):1021-31. PubMed ID: 23164454 [TBL] [Abstract][Full Text] [Related]
9. Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice. Tyhon A; Lakaye B; Grisar T; Tirelli E Pharmacol Biochem Behav; 2008 Feb; 88(4):446-55. PubMed ID: 17996928 [TBL] [Abstract][Full Text] [Related]
10. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity. Miller DK; Dopheide MM; Smith SM; Casteel SW Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525 [TBL] [Abstract][Full Text] [Related]
11. Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. Spielewoy C; Biala G; Roubert C; Hamon M; Betancur C; Giros B Psychopharmacology (Berl); 2001 Dec; 159(1):2-9. PubMed ID: 11797063 [TBL] [Abstract][Full Text] [Related]
12. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013 [TBL] [Abstract][Full Text] [Related]
13. [Effects of antagonists of the various subtypes of dopamine receptors on the locomotor activity of C57BL mice induced by psychostimulators]. Novoselov IA; Raevskiĭ KS Eksp Klin Farmakol; 2003; 66(6):3-5. PubMed ID: 14743700 [TBL] [Abstract][Full Text] [Related]
14. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats. Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403 [TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors. Kwiatkowski MA; Hellemann G; Sugar CA; Cope ZA; Minassian A; Perry W; Geyer MA; Young JW Pharmacol Biochem Behav; 2019 Mar; 178():42-50. PubMed ID: 29289701 [TBL] [Abstract][Full Text] [Related]
16. Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. Paterson NE; Ricciardi J; Wetzler C; Hanania T Neurosci Res; 2011 Jan; 69(1):41-50. PubMed ID: 20934466 [TBL] [Abstract][Full Text] [Related]
17. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration. Kuribara H Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603 [TBL] [Abstract][Full Text] [Related]
18. D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice. Huotari M; García-Horsman JA; Karayiorgou M; Gogos JA; Männistö PT Psychopharmacology (Berl); 2004 Feb; 172(1):1-10. PubMed ID: 14574438 [TBL] [Abstract][Full Text] [Related]